.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Diflunisal - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for diflunisal?

Diflunisal is the generic ingredient in two branded drugs marketed by Watson Labs, Idt Australia Ltd, Heritage Pharma, Merck, Roxane, Teva, and Purepac Pharm, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for diflunisal. Seven suppliers are listed for this compound.

Summary for Generic Name: diflunisal

Tradenames:2
Patents:1
Applicants:7
NDAs:9
Drug Master File Entries: see list7
Suppliers / Packagers: see list7
Bulk Api Vendors: see list58
Clinical Trials: see list3
Patent Applications: see list6,665
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diflunisal at DailyMed

Pharmacology for Ingredient: diflunisal

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-002Apr 19, 1982DISCNYesNo► Subscribe► Subscribe
Idt Australia Ltd
DIFLUNISAL
diflunisal
TABLET;ORAL074604-001Jun 10, 1996DISCNNoNo► Subscribe► Subscribe
Watson Labs
DIFLUNISAL
diflunisal
TABLET;ORAL074400-002Jul 17, 1997DISCNNoNo► Subscribe► Subscribe
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-001Apr 19, 1982DISCNYesNo► Subscribe► Subscribe
Roxane
DIFLUNISAL
diflunisal
TABLET;ORAL073563-001Nov 27, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: diflunisal

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-001Apr 19, 19823,674,870► Subscribe
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-001Apr 19, 19823,714,226► Subscribe
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-002Apr 19, 19823,714,226► Subscribe
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-002Apr 19, 19823,674,870► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc